Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Microsoft has launched its Model Context Protocol (MCP) for Azure Functions, ensuring secure, standardized workflows for AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback